BarnesTREDrakeRPatonC, et al. (2020) Evidence-based guidelines for the pharmacological treatment of schizophrenia: Updated recommendations from the British Association for Psychopharmacology. J Psychopharmacol34: 3–78.
2.
ChouinardGSamahaANChouinardVA, et al. (2017) Antipsychotic-induced dopamine supersensitivity psychosis: Pharmacology, criteria, and therapy. Psychother Psychosom86: 189–219.
HuiCLMHonerWGLeeEHM, et al. (2019) Predicting first-episode psychosis patients who will never relapse over 10 years. Psychol Med49: 2206–2214.
5.
LakoIMVan Den HeuvelERKnegteringH, et al. (2013) Estimating dopamine d2 receptor occupancy for doses of 8 antipsychotics: A meta-analysis. J Clin Psychopharmacol33: 675–681.
